ZIMVIE INC (ZIMV) Stock Fundamental Analysis
NASDAQ:ZIMV - US98888T1079 - Common Stock
18.88 USD
-0.02 (-0.11%)
18.88 USD
0 (0%)
Taking everything into account, ZIMV scores 4 out of 10 in our fundamental rating. ZIMV was compared to 185 industry peers in the Health Care Equipment & Supplies industry. ZIMV has an average financial health and profitability rating. ZIMV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ZIMV was profitable.
In the past year ZIMV had a positive cash flow from operations.
In the past 5 years ZIMV always reported negative net income.
ZIMV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ZIMV's Return On Assets of -2.57% is fine compared to the rest of the industry. ZIMV outperforms 65.95% of its industry peers.
ZIMV's Return On Equity of -4.72% is fine compared to the rest of the industry. ZIMV outperforms 67.03% of its industry peers.
ZIMV has a Return On Invested Capital of 0.77%. This is in the better half of the industry: ZIMV outperforms 65.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.57% | ||
| ROE | -4.72% | ||
| ROIC | 0.77% |
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ZIMV's Operating Margin of 1.42% is fine compared to the rest of the industry. ZIMV outperforms 64.86% of its industry peers.
The Gross Margin of ZIMV (65.31%) is better than 68.65% of its industry peers.
In the last couple of years the Gross Margin of ZIMV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.42% | ||
| PM (TTM) | N/A | ||
| GM | 65.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ZIMV is destroying value.
The number of shares outstanding for ZIMV has been increased compared to 1 year ago.
Compared to 5 years ago, ZIMV has more shares outstanding
ZIMV has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.90, we must say that ZIMV is in the distress zone and has some risk of bankruptcy.
ZIMV has a Altman-Z score (0.90) which is comparable to the rest of the industry.
ZIMV has a debt to FCF ratio of 39.31. This is a negative value and a sign of low solvency as ZIMV would need 39.31 years to pay back of all of its debts.
ZIMV's Debt to FCF ratio of 39.31 is fine compared to the rest of the industry. ZIMV outperforms 66.49% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that ZIMV is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, ZIMV is doing worse than 64.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 39.31 | ||
| Altman-Z | 0.9 |
ROIC/WACC0.11
WACC7.18%
2.3 Liquidity
ZIMV has a Current Ratio of 2.37. This indicates that ZIMV is financially healthy and has no problem in meeting its short term obligations.
ZIMV's Current ratio of 2.37 is in line compared to the rest of the industry. ZIMV outperforms 44.86% of its industry peers.
A Quick Ratio of 1.60 indicates that ZIMV should not have too much problems paying its short term obligations.
ZIMV has a Quick ratio of 1.60. This is comparable to the rest of the industry: ZIMV outperforms 44.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.6 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 142.11% over the past year.
ZIMV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.48%.
The Revenue for ZIMV have been decreasing by -15.69% on average. This is quite bad
EPS 1Y (TTM)142.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%
3.2 Future
Based on estimates for the next years, ZIMV will show a very strong growth in Earnings Per Share. The EPS will grow by 20.02% on average per year.
ZIMV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.42% yearly.
EPS Next Y57.15%
EPS Next 2Y26.8%
EPS Next 3Y20.02%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y0.64%
Revenue Next 3Y0.42%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.52, which indicates a rather expensive current valuation of ZIMV.
Compared to the rest of the industry, the Price/Earnings ratio of ZIMV indicates a somewhat cheap valuation: ZIMV is cheaper than 79.46% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.08, ZIMV is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 19.90, the valuation of ZIMV can be described as rather expensive.
78.92% of the companies in the same industry are more expensive than ZIMV, based on the Price/Forward Earnings ratio.
ZIMV's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.72.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.52 | ||
| Fwd PE | 19.9 |
4.2 Price Multiples
ZIMV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ZIMV is cheaper than 77.30% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZIMV is valued a bit cheaper than 69.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 94.8 | ||
| EV/EBITDA | 16.68 |
4.3 Compensation for Growth
ZIMV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZIMV's earnings are expected to grow with 20.02% in the coming years.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y26.8%
EPS Next 3Y20.02%
5. Dividend
5.1 Amount
No dividends for ZIMV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
18.88
-0.02 (-0.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners85.01%
Inst Owner Change-0.12%
Ins Owners2.61%
Ins Owner Change25.13%
Market Cap532.42M
Analysts48.89
Price Target16.32 (-13.56%)
Short Float %2.89%
Short Ratio1.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.01%
Min EPS beat(2)21.96%
Max EPS beat(2)26.05%
EPS beat(4)4
Avg EPS beat(4)32.05%
Min EPS beat(4)1.94%
Max EPS beat(4)78.25%
EPS beat(8)7
Avg EPS beat(8)120.45%
EPS beat(12)10
Avg EPS beat(12)160.71%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-3.18%
Max Revenue beat(2)1.35%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.35%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.38%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)37.14%
PT rev (3m)-7.41%
EPS NQ rev (1m)-11.7%
EPS NQ rev (3m)-15.74%
EPS NY rev (1m)7.11%
EPS NY rev (3m)8.86%
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)-6.65%
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.52 | ||
| Fwd PE | 19.9 | ||
| P/S | 1.2 | ||
| P/FCF | 94.8 | ||
| P/OCF | 44.49 | ||
| P/B | 1.29 | ||
| P/tB | 8.86 | ||
| EV/EBITDA | 16.68 |
EPS(TTM)0.92
EY4.87%
EPS(NY)0.95
Fwd EY5.02%
FCF(TTM)0.2
FCFY1.05%
OCF(TTM)0.42
OCFY2.25%
SpS15.72
BVpS14.64
TBVpS2.13
PEG (NY)0.36
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.57% | ||
| ROE | -4.72% | ||
| ROCE | 0.97% | ||
| ROIC | 0.77% | ||
| ROICexc | 0.86% | ||
| ROICexgc | 2.21% | ||
| OM | 1.42% | ||
| PM (TTM) | N/A | ||
| GM | 65.31% | ||
| FCFM | 1.27% |
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 39.31 | ||
| Debt/EBITDA | 5.39 | ||
| Cap/Depr | 18.32% | ||
| Cap/Sales | 1.43% | ||
| Interest Coverage | 0.43 | ||
| Cash Conversion | 29.2% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.6 | ||
| Altman-Z | 0.9 |
F-Score6
WACC7.18%
ROIC/WACC0.11
Cap/Depr(3y)17.11%
Cap/Depr(5y)24.69%
Cap/Sales(3y)2.37%
Cap/Sales(5y)3.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
EPS Next Y57.15%
EPS Next 2Y26.8%
EPS Next 3Y20.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%
Revenue Next Year0.03%
Revenue Next 2Y0.64%
Revenue Next 3Y0.42%
Revenue Next 5YN/A
EBIT growth 1Y126.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.32%
EBIT Next 3Y44.17%
EBIT Next 5YN/A
FCF growth 1Y117.33%
FCF growth 3Y-0.91%
FCF growth 5Y-35.32%
OCF growth 1Y192.13%
OCF growth 3Y-39.59%
OCF growth 5Y-34.68%